Teva Said To Beat Pfizer, Actavis To Win Merckle's Ratiopharm
Source: Business Week
Thursday 18th March, 2010
March 18 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is close to an agreement to buy Ratiopharm GmbH for about 3.5 billion euros ($4.78 billion), ending a nine-month battle for Germany's ... ...
Read the full story at
Business Week
Email this story to a friend
Have your say on this story
